Metraipolis › archive › dc_2b0488cb3fca

Management and Prognosis of Anti-MDA5 Dermatomyositis: Insights from a National Multicenter Cohort — Europe PMC PMID:41898353

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41898353
DOI: 10.3390/biomedicines14030709
License (as archived): solo-consultazione
Archived: 2026-11-04T05:46:14.964Z
SHA-256 of the archived text: 2cbc68892740897c14d1b431e0dc220abc7da2ef944188532a391732789c3976
Stable URL of this page: https://metraipolis.com/documento/dc_2b0488cb3fca

How to cite

Management and Prognosis of Anti-MDA5 Dermatomyositis: Insights from a National Multicenter Cohort — Europe PMC PMID:41898353 — Europe PMC (en), https://europepmc.org/article/MED/41898353 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b0488cb3fca (Metraipolis archive dc_2b0488cb3fca, sha256 2cbc68892740897c14d1b431e0dc220abc7da2ef944188532a391732789c3976)

BibTeX

@misc{dc2b0488cb3fca,
  title = {Management and Prognosis of Anti-MDA5 Dermatomyositis: Insights from a National Multicenter Cohort — Europe PMC PMID:41898353},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41898353},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b0488cb3fca; sha256 2cbc68892740897c14d1b431e0dc220abc7da2ef944188532a391732789c3976},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41898353. Agents can read the archived copy with the MCP tool read_document.